Suppression of myoclonus in SCA2 by piracetam
- PMID: 16149096
- DOI: 10.1002/mds.20683
Suppression of myoclonus in SCA2 by piracetam
Abstract
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
Copyright (c) 2005 Movement Disorder Society.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
